Breaking News, Trials & Filings

Roche Trial to Assess Actemra/RoActemra in COVID-19 Pneumonia

First Phase III global study of Actemra/RoActemra in this setting to evaluate the safety and efficacy in collaboration with BARDA

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Roche is working with the FDA to initiate a randomized, double-blind, placebo-controlled Phase III trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), to evaluate the safety and efficacy of Actemra/RoActemra (tocilizumab) plus standard of care in hospitalized adult patients with severe COVID-19 pneumonia compared to placebo plus standard of care. 

 This is the first global study of Actemra/RoActemra in this setting and is expected to begin enrollin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters